How Lipoprotein(a) Raises Your Heart Disease Risk

When it comes to heart disease, cholesterol levels often take center stage. Doctors routinely measure LDL (bad cholesterol), HDL (good cholesterol), and triglycerides to assess cardiovascular risk. But there’s another critical player that often goes unnoticed—Lipoprotein(a), or Lp(a). This overlooked molecule can silently increase the risk of heart attacks, strokes, and other cardiovascular conditions, yet it is rarely tested in standard lipid panels.

Lipoprotein(a) is a type of lipoprotein, similar to LDL cholesterol but with a crucial difference—it has an additional protein called apolipoprotein(a), which makes it more prone to causing blood clot formation and arterial damage. Unlike LDL, which can often be controlled through diet and lifestyle changes, Lp(a) levels are primarily determined by genetics. This means that even individuals with healthy cholesterol levels and no traditional risk factors can still have an elevated risk of cardiovascular disease due to high Lp(a).

Why Lipoprotein(a) Is a Silent Threat

One of the biggest dangers of Lp(a) is that it doesn’t cause noticeable symptoms. Many people with high levels feel completely fine until a major cardiac event occurs. Since Lp(a) promotes plaque buildup, inflammation, and clot formation, individuals with elevated levels are more susceptible to heart disease, even in the absence of high LDL cholesterol or high blood pressure. This silent nature makes Lp(a) a particularly insidious risk factor.

Unlike other cholesterol-related markers that can be influenced by lifestyle, Lp(a) is primarily inherited. If one or both of your parents have high Lp(a) levels, there is a strong chance you do too. This genetic link makes it different from other modifiable cardiovascular risk factors. Standard cholesterol-lowering medications like statins have little to no effect on Lp(a), making it even more challenging to manage.

How Lipoprotein(a) Contributes to Cardiovascular Disease

High levels of Lp(a) contribute to cardiovascular disease in multiple ways:

• Increased Plaque Buildup: Lp(a) accelerates the formation of arterial plaque, narrowing blood vessels and restricting blood flow.
• Promotes Blood Clots: The apolipoprotein(a) component makes Lp(a) more likely to cause clot formation, increasing the risk of heart attacks and strokes.
• Triggers Inflammation: Elevated Lp(a) contributes to chronic inflammation in blood vessels, making them more vulnerable to damage.
• Affects Aortic Valve Health: High Lp(a) is linked to aortic valve stenosis, a condition where the heart’s main valve stiffens, making it harder for blood to flow properly.

Who Should Get Tested for Lipoprotein(a)?

Since Lp(a) testing is not part of standard cholesterol panels, many people with elevated levels remain unaware of their risk. However, certain individuals should strongly consider testing, including:

• Those with a family history of premature heart disease or stroke
• Individuals with heart disease despite normal cholesterol levels
• People with a history of recurrent blood clots or aortic valve disease
• Those with high cholesterol that doesn’t respond well to standard treatment

Lp(a) levels remain relatively stable throughout life, so a single test can provide valuable long-term insights into cardiovascular risk.

How High Is Too High?

Lipoprotein(a) is measured in milligrams per deciliter (mg/dL) or nanomoles per liter (nmol/L). Generally, an Lp(a) level above 50 mg/dL (or 125 nmol/L) is considered elevated and associated with increased cardiovascular risk. Some individuals have Lp(a) levels that are significantly higher, placing them at even greater risk. Since there is no universal consensus on a “safe” Lp(a) level, early testing and risk assessment are critical.

Unlike LDL cholesterol, which can be reduced through diet, exercise, and statins, there are currently no widely available medications that specifically lower Lp(a). However, emerging therapies are in development, including:

• Lipoprotein(a)-Lowering Drugs: Experimental treatments like antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs) show promise in reducing Lp(a) levels by targeting its production at the genetic level.
• Niacin (Vitamin B3): Some studies suggest niacin can modestly lower Lp(a), but its effectiveness varies and is not a primary treatment strategy.
• Apheresis: In severe cases, lipid apheresis—a dialysis-like procedure—can physically remove Lp(a) from the blood, though it is typically reserved for individuals at extreme cardiovascular risk.

Lifestyle and Diet

Although Lp(a) is primarily genetically determined, maintaining overall heart health can still make a difference. Strategies that may help reduce the impact of high Lp(a) include:

• Managing LDL Cholesterol: Since Lp(a) adds to LDL’s harmful effects, keeping LDL levels low through diet and medication is crucial.
• Anti-Inflammatory Diet: Consuming omega-3-rich foods (such as fatty fish), fiber, and antioxidant-rich fruits and vegetables can help reduce inflammation.
• Exercise: Regular physical activity supports cardiovascular health, although it does not directly lower Lp(a) levels.
• Avoiding Smoking and Excess Alcohol: These habits can exacerbate endothelial dysfunction and inflammation, compounding the risks of high Lp(a).

The Role of Lp(a) in Stroke and Heart Attacks

Lp(a) is not just a risk factor for heart disease—it’s also strongly linked to strokes. High Lp(a) can increase the likelihood of ischemic strokes (caused by blood clots) and transient ischemic attacks (mini-strokes). This makes testing particularly important for individuals with unexplained stroke histories or those with a family history of stroke at a young age.

Lipoprotein(a) and Women’s Heart Health

Many women assume they are at lower risk for heart disease, especially before menopause. However, Lp(a)-related cardiovascular risks apply to both men and women. Hormonal changes, particularly post-menopause, can further increase the impact of Lp(a) on cardiovascular health. Women with high Lp(a) should be proactive about monitoring their heart health, especially if they have additional risk factors like hypertension or diabetes.

Despite its significant impact on heart disease risk, Lp(a) remains under-tested and under-discussed in routine medical care. Increased awareness among both patients and healthcare providers is essential for early detection and prevention. Routine testing in individuals with a strong family history of heart disease could help identify at-risk individuals before they experience major cardiovascular events.

Understanding how Lipoprotein(a) contributes to heart disease risk allows individuals to take proactive steps in managing their cardiovascular health. While Lp(a) cannot currently be controlled with standard cholesterol-lowering treatments, early detection and risk management strategies can make a significant difference in preventing heart attacks, strokes, and other life-threatening conditions.